The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2019

Filed:

Apr. 19, 2018
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Rachel R. Caspi, Bethesda, MD (US);

Wai Po Chong, Mongkok, HK;

Reiko Yamane, Rockville, MD (US);

Mary Mattapallil, Rockville, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/20 (2006.01); A61K 47/68 (2017.01); A61K 38/17 (2006.01); A61K 38/22 (2006.01); A61P 27/02 (2006.01); A61K 9/00 (2006.01); A61P 37/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/20 (2013.01); A61K 9/0019 (2013.01); A61K 38/1774 (2013.01); A61K 38/22 (2013.01); A61K 47/68 (2017.08); A61P 27/02 (2018.01); A61P 37/06 (2018.01); A61K 9/0048 (2013.01);
Abstract

Methods are provided for treating ocular surface inflammation and/or uveitis in a subject. The methods can include selecting a subject with uveitis and/or ocular surface disease. The methods can then include administering to the subject a therapeutically effective amount of an interleukin 24 (IL-24) polypeptide or nucleic acid encoding the IL-24 polypeptide. In some examples, the administered IL-24 polypeptide suppresses production of effector cytokines by Th17 cells. A pharmaceutical composition is further provided here that includes an IL-24 polypeptide or nucleic acid encoding the polypeptide. In some examples, the IL-24 polypeptide is a variant of IL-24 or an Fc fusion protein that includes IL-24. The pharmaceutical composition can be used in any of the methods provided herein to treat ocular surface inflammation and/or uveitis.


Find Patent Forward Citations

Loading…